WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 2801 Infant (under 12 months) mortality rate: 672
GDP / capita (US$): 7711 Child (under 5 years) mortality rate: 1042

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 10'163  9'850  9'540  9'233  8'927  6'674  5'606  4'127 
Births 455  443  431  417  403  288  277  210 
Surviving infants 416  405  393  380  366  258  245  185 
Pop. less than 5 years 1'897  1'838  1'769  1'685  1'616  1'197  1'135  782 
Pop. less than 15 years 4'529  4'370  4'213  4'056  3'936  3'269  2'682  1'831 
Female 15-49 years 2'419  2'353  2'287  2'221  2'140  1'447  1'234  974 

Number of reported case

(Click for retrospective incidence data for Burundi)
Diphtheria
Japanese encephalitis
Measles 49  129  495  305  18'363  13'282  49'227 
Mumps
Pertussis 72  529  9'613 
Polio* 10  43 
Rubella 11  67  247  305 
Rubella (CRS)
Tetanus (neonatal) 11  16  25 
Tetanus (total) 11  33  65  256 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Burundi)
Vaccine year result method % card seen                                                
BCG 2011  98  EPI   51  95  98  90  93  98  73  97 
DTP1 2011  99  EPI   51  98  98  99*  99  99*  74 
DTP3 2011  98  EPI   51  96  96  99*  96  99*  68  86 
HepB_BD         
HepB3 2011  98  EPI   51  96  96  99*  96  99* 
Hib3 2011  98  EPI   51  96  96  99*  96  99* 
JapEnc         
MCV 2011  97  EPI   51  98  93  99*  92  91  61  74 
MCV2          51 
PCV1          98  99*  31 
PCV3          96  99*  14 
Pol3 2011  98  EPI   51  96  96  99*  94  96  69  97 
Rota1          14 
Rota_last         
Rubella1         
TT2plus 2009  32  DHS   62  96  88  99*  94  88  28  56 
PAB         
VAD1          27  27  72  89 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Burundi)
BCG 95  98  90  93  98  85  97 
DTP1 98  98  99  99  99  88  95 
DTP3 96  96  96  96  94  80  86 
HepB3 96  96  96  96  94 
HepB_BD
Hib3 96  96  96  96  94 
MCV 98  93  93  92  91  72  74 
MCV2 51 
PAB 85  85  80  94  94  51  67 
PnC3 96  96  14 
Pol3 96  96  95  94  96  71  97 
Rota_last
YFV

Number of districts in the country 45  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 67
From 80 to 89% 27
From 50 to 79% 7
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; Yes From December 2014
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 1st contact; +1, +6 months; No From December 2015
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td st contact; +1,+6 months; +1, +1 year; Yes
VitaminA 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2010-2014  2010-2014  2006 - 2010  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 45  45  45  45  45  12  17 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 45  45  45  45  43  41  17 
Nº districts with DTP3 coverage >=80% number 42  42  44  41  39  30 
% of districts with DTP3 coverage >=80% From 0 to 100% 93  93  98  91  91  73 
Nº districts with measles (MCV1) coverage >=95% number 27  31  29  16  24  11   
% of districts with MCV1 coverage >=95% From 0 to 100% 60  69  64  36  56  27   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%   NA 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.